Private eye hospital opens in Romania

Article

Romania has opened the Europe Eye Hospital in Bucharest this month. This private eye hospital is reportedly the largest in south-eastern Europe and will mean Romanians won't have to travel far for cataract treatments and other surgical procedures.

Romania has opened the Europe Eye Hospital in Bucharest this month. This private eye hospital is reportedly the largest in south-eastern Europe and will mean Romanians won't have to travel far for cataract treatments and other surgical procedures.

Europe Eye Hospital will provide complete eye diagnosis and treatment for diseases such as glaucoma, eye trauma, vitreoretinal diseases, corneal transplants and ocular inflammations. All surgery will be completed at the highest European standards. The hospital is capable of screening a minimum of 600 patients daily and can complete 30,000 general eye surgeries and 25,000 laser operations annually.

The hospital features 30 in-patient rooms, 3 VIP rooms and 4 postoperative rooms, 8 operating theatres and 12 examination rooms – all furnished to a high standard with the latest in ophthalmic technology. The equipment includes 2 Schwind Amaris excimer lasers, Mel 80 Zeiss lasers, the Cirrus HD Zeiss to perform OCT for in vivo retina biopsy and the Visucam 500 fundus camera.

Professor Dr Carstocea said: "The Europe Eye Hospital will also provide early and timely diagnosis and treatment to save vision of children in its dedicated pediatric unit. Thirty surgeons with international experience from Romania and from other European countries will practice in the modern facility offering various treatments for vision correction, cataracts, glaucoma, retinal disease and age-related macular degeneration. They will perform intraocular implants of highest technology."

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.